Sex, Brinkman Index, And Pleural Glucose Levels As Predictors Of Pleurodesis Outcome In Malignant Pleural Effusion: Evidence From Rsud Jenderal Ahmad Yani Metro (2023–2024)

Authors

  • Fransisca TY Sinaga Program Studi Pendidikan Kedokteran, Fakultas Kedokteran , Universitas Malahayati, Lampung, Indonesia & Departemen Pulmonologi dan Respirasi, Fakultas Kedokteran, Universitas Lampung, Rumah Sakit Dr. H. Abdul Moeloek Lampung, Indonesia
  • Fitriyah Shahab Program Studi Pendidikan Kedokteran, Fakultas Kedokteran, Universitas Malahayati, Lampung, Indonesia & Departemen Pulmonologi dan Respiratory, Rumah Sakit BARI, Palembang, Indonesia
  • Achmad Gozali Program Studi Pendidikan Kedokteran, Fakultas Kedokteran, Universitas Malahayati, Lampung, Indonesia
  • Retno Ariza S Soemarwoto Program Studi Pendidikan Kedokteran, Fakultas Kedokteran, Universitas Malahayati, Lampung, Indonesia
  • Muhammad Junus Didiek Herdarto Program Studi Pendidikan Kedokteran, Fakultas Kedokteran, Universitas Malahayati, Lampung, Indonesia
  • Andreas Infianto Program Studi Pendidikan Kedokteran, Fakultas Kedokteran, Universitas Malahayati, Lampung, Indonesia & Departemen Pulmonologi dan Respiratory, Rumah Sakit BARI, Palembang, Indonesia
  • Apri Lyanda Program Studi Pendidikan Kedokteran, Fakultas Kedokteran, Universitas Malahayati, Lampung, Indonesia
  • Hidayat Hidayat Program Studi Pendidikan Kedokteran, Facultas Kedokteran, Universitas Malahayati, Lampung, Indonesia

DOI:

https://doi.org/10.33533/jpm.v20i1.12348

Keywords:

Adenocarcinoma; Brinkman Index; Glucose; Malignant pleural effusion; Pleurodesis; Sex

Abstract

Malignant pleural effusion (MPE) is a frequent complication of advanced adenocarcinoma, leading to dyspnea and impaired quality of life. Pleurodesis is the standard palliative approach, but outcomes vary. This study evaluated the association of sex, smoking exposure (Brinkman Index), and pleural glucose with pleurodesis success.

An observational analytic study was conducted at RSUD Jenderal Ahmad Yani Metro, Lampung, from July 2023 to July 2024. Thirty-eight patients with adenocarcinoma-related MPE were recruited; six were excluded, leaving 32 eligible subjects who underwent bleomycin pleurodesis. Outcomes were categorized as complete response (CR), partial response (PR), or failure. Associations between predictive factors and pleurodesis outcomes were analyzed using the Chi-Square test.

Pleurodesis success correlated significantly with sex (p = 0.042), Brinkman Index (p = 0.027), and pleural glucose (p < 0.001). Females achieved higher CR rates (53.8%) than males (15.8%). Lower Brinkman Index values were linked to better outcomes, while pleural glucose >60 mg/dL strongly predicted success.

Conclusion: Sex, smoking exposure, and pleural glucose may predict pleurodesis outcomes in adenocarcinoma-related MPE. Female sex, lower smoking burden, and higher pleural glucose were associated with improved pleural adhesion, supporting their role in guiding treatment.

References

Acencio MMP, et al. Evaluation of cellular alterations and inflammatory profile of mesothelial cells and/or neoplastic cells exposed to talc used for pleurodesis. Oncotarget. 2020;11(41):3730–3736. Available from: https://doi.org/10.18632/oncotarget.27750

Alsayed S, et al. Malignant pleural effusion biomarkers as predictor for chemical pleurodesis success. Egypt J Chest Dis Tuberc. 2015;64(1):153–160. Available from: https://doi.org/10.1016/j.ejcdt.2014.08.005

Aydin Y, et al. Malignant pleural effusions: appropriate treatment approaches. Eurasian J Med. 2009;41(3):186–193. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25610100

Bibby AC, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018;52(1):1–23. Available from: https://doi.org/10.1183/13993003.00349-2018

Charalampidis C, et al. Physiology of the pleural space. J Thorac Dis. 2015;7(Suppl 1):S33–S37. Available from: https://doi.org/10.3978/j.issn.2072-1439.2014.12.48

Charalampidis C, et al. Pleura space anatomy. J Thorac Dis. 2015;7(Suppl 1):S27–S32. Available from: https://doi.org/10.3978/j.issn.2072-1439.2015.01.48

Rodriguez-Panadero F, Antony VB. Pleurodesis: State of the art. Eur Respir J. 1997;10(7):1648–1654. Available from: https://doi.org/10.1183/09031936.97.10071648

Divisi D, Crisci R. Malignant pleural effusions. J Xiangya Med. 2021;6:13–22. Available from: https://doi.org/10.21037/jxym-20-121

Dixit R, et al. Diagnosis and management options in malignant pleural effusions. Lung India. 2017;34(2):160–166. Available from: https://doi.org/10.4103/0970-2113.201305

Shehata SM, Sileem AE, El-Fakharany KM. Pleural fluid CRP, LDH, and pH as predictors of successful pleurodesis in malignant pleural effusions. Egypt J Chest Dis Tuberc. 2015;64(3):593–599. Available from: https://doi.org/10.1016/j.ejcdt.2015.05.003

Dugan KC, et al. Management of Persistent Air Leaks. Chest. 2017;152(2):417–423. Available from: https://doi.org/10.1016/j.chest.2017.02.020

Feller-Kopman DJ, et al. Management of malignant pleural effusions: An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198(7):839–849. Available from: https://doi.org/10.1164/rccm.201807-1415ST

Fysh ETH, et al. Pleurodesis outcome in malignant pleural mesothelioma. Thorax. 2013;68(6):594–596. Available from: https://doi.org/10.1136/thoraxjnl-2012-203043

Hamouda D, Elsayed E, Alawady SM. Pleurodesis using bleomycin ampoules, doxycycline capsules and povidone iodine solution in patients with malignant pleural effusion in Zagazig University Hospitals. Zagazig Univ Med J. 2022;28(5):1022–1028. Available from: https://doi.org/10.21608/ZUMJ.2022.118927.2466

Ibrahim IM, et al. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion. J Cardiothorac Surg. 2015;10(1):1–6. Available from: https://doi.org/10.1186/s13019-015-0270-5

Kishi K, et al. Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions. Eur Respir J. 2004;24(2):263–266. Available from: https://doi.org/10.1183/09031936.04.00137403

Kisseleva T, Brenner DA. Fibrogenesis of parenchymal organs. Proc Am Thorac Soc. 2008;5(3):338–342. Available from: https://doi.org/10.1513/pats.200711-168DR

Light RW. Pleural Diseases. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.

Marhana IA, Handoko AT. Hubungan nilai pH cairan pleura dengan hasil pleurodesis pada penderita efusi pleura karena keganasan. Jurnal Respirasi. 2019;3(1):1–6. Available from: https://doi.org/10.20473/jr.v3-i.1.2017.1-6

Mierzejewski M, et al. Chemical pleurodesis – A review of mechanisms involved in pleural space obliteration. Respir Res. 2019;20(1):1–16. Available from: https://doi.org/10.1186/s12931-019-1204-x

Downloads

Published

2026-06-03

How to Cite

Sinaga, F. T., Shahab, F., Gozali, A., Soemarwoto, R. A. S., Herdarto, M. J. D., Infianto, A., Lyanda, A., & Hidayat, H. (2026). Sex, Brinkman Index, And Pleural Glucose Levels As Predictors Of Pleurodesis Outcome In Malignant Pleural Effusion: Evidence From Rsud Jenderal Ahmad Yani Metro (2023–2024). Jurnal Profesi Medika : Jurnal Kedokteran Dan Kesehatan, 20(1), 30–36. https://doi.org/10.33533/jpm.v20i1.12348